Mednax Historical Income Statement
| MD Stock | USD 9.24 0.16 1.70% |
Historical analysis of Mednax income statement accounts such as Gross Profit of 542.2 M, Other Operating Expenses of 1.3 B or Operating Income of 7 M can show how well Mednax Inc performed in making a profits. Evaluating Mednax income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Mednax's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Mednax Inc latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Mednax Inc is a good buy for the upcoming year.
Mednax |
About Mednax Income Statement Analysis
Mednax Inc Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Mednax shareholders. The income statement also shows Mednax investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Mednax Income Statement Chart
Mednax Inc Income Statement is one of the three primary financial statements used for reporting Mednax's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Mednax Inc revenue and expense. Mednax Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At present, Mednax's EBIT is projected to decrease significantly based on the last few years of reporting. The current year's EBITDA is expected to grow to about 288.6 M, whereas Interest Expense is forecasted to decline to about 24.4 M. Add Fundamental
Total Revenue
Total revenue comprises all receipts Mednax Inc generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Gross Profit
Gross profit is a required income statement account that reflects total revenue of Mednax Inc minus its cost of goods sold. It is profit before Mednax operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Mednax Inc. It is also known as Mednax overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Operating Income
Operating Income is the amount of profit realized from Mednax Inc operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Mednax Inc is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.Most accounts from Mednax's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Mednax Inc current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mednax Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. At present, Mednax's EBIT is projected to decrease significantly based on the last few years of reporting. The current year's EBITDA is expected to grow to about 288.6 M, whereas Interest Expense is forecasted to decline to about 24.4 M.
| 2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 513.2M | 467.0M | 421.6M | 542.2M | Total Revenue | 1.9B | 2.0B | 2.0B | 1.5B |
Mednax income statement Correlations
Click cells to compare fundamentals
Mednax Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Mednax income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Depreciation And Amortization | 78.9M | 28.4M | 48.9M | 64.7M | 36.2M | 34.2M | |
| Interest Expense | 119.4M | 110.5M | 68.7M | 39.7M | 42.1M | 24.4M | |
| Total Revenue | 3.5B | 1.7B | 1.9B | 2.0B | 2.0B | 1.5B | |
| Gross Profit | 892.0M | 449.3M | 513.2M | 467.0M | 421.6M | 542.2M | |
| Other Operating Expenses | 3.1B | 1.6B | 1.7B | 1.8B | 1.8B | 1.3B | |
| Operating Income | 416.3M | 173.5M | 202.9M | 172.7M | 7.3M | 7.0M | |
| Ebit | 416.3M | 173.5M | 202.9M | 172.7M | 159.9M | 254.3M | |
| Ebitda | 495.1M | 202.0M | 251.8M | 237.4M | 196.1M | 288.6M | |
| Cost Of Revenue | 2.6B | 1.3B | 1.4B | 1.5B | 1.6B | 977.3M | |
| Total Operating Expenses | 483.5M | 277.4M | 295.5M | 267.0M | 263.7M | 312.8M | |
| Income Before Tax | (1.2B) | 7.1M | 135.2M | 81.4M | (48.4M) | (45.9M) | |
| Total Other Income Expense Net | (1.7B) | (166.4M) | (67.7M) | (91.3M) | (164.1M) | (155.9M) | |
| Net Income | (1.2B) | (9.6M) | 131.0M | 66.3M | (60.4M) | (57.4M) | |
| Income Tax Expense | (91.9M) | 16.7M | 27.2M | 18.8M | 12.0M | 11.4M | |
| Selling General Administrative | 404.6M | 248.9M | 263.4M | 231.4M | 227.5M | 228.2M | |
| Net Income Applicable To Common Shares | (1.5B) | (796.5M) | 131.0M | 66.3M | 59.7M | 48.1M | |
| Net Income From Continuing Ops | (1.2B) | (9.6M) | 108.0M | 62.6M | (60.4M) | (57.4M) | |
| Tax Provision | (91.9M) | 16.7M | 27.2M | 18.8M | 12.0M | 11.4M | |
| Interest Income | 105.9M | 91.0M | 53.2M | 34.3M | 39.4M | 69.6M | |
| Net Interest Income | (119.4M) | (110.5M) | (68.7M) | (39.7M) | (42.1M) | (44.2M) | |
| Discontinued Operations | (1.5B) | (786.9M) | 23.0M | 3.8M | 3.4M | 3.6M | |
| Reconciled Depreciation | 78.9M | 28.4M | 32.1M | 35.6M | 36.2M | 48.6M | |
| Extraordinary Items | (347.6M) | (786.9M) | 23.0M | 3.8M | 3.4M | 3.6M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mednax Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. Note that the Mednax Inc information on this page should be used as a complementary analysis to other Mednax's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Complementary Tools for Mednax Stock analysis
When running Mednax's price analysis, check to measure Mednax's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mednax is operating at the current time. Most of Mednax's value examination focuses on studying past and present price action to predict the probability of Mednax's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mednax's price. Additionally, you may evaluate how the addition of Mednax to your portfolios can decrease your overall portfolio volatility.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |
Is Mednax's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mednax. If investors know Mednax will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mednax listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.31) | Revenue Per Share 24.265 | Quarterly Revenue Growth (0.03) | Return On Assets 0.0432 | Return On Equity (0.07) |
The market value of Mednax Inc is measured differently than its book value, which is the value of Mednax that is recorded on the company's balance sheet. Investors also form their own opinion of Mednax's value that differs from its market value or its book value, called intrinsic value, which is Mednax's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mednax's market value can be influenced by many factors that don't directly affect Mednax's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mednax's value and its price as these two are different measures arrived at by different means. Investors typically determine if Mednax is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mednax's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.